BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

UCB at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

UCB takes part in 1 session at BIO-Europe 2026 in Cologne. Its session looks at women's health as healthcare's largest underserved market and biggest growth opportunity, alongside the European Investment Bank and the Women's Health Fund, among others.

OrganizationBIO-Europe 2026 Attendance
UCB
Brussels, Belgium
Large pharma
Biopharmaceutical company developing and marketing medicines for immunology and neurology.
Panel
Tue Nov 10
11:15–12:15
Women’s Health: Healthcare’s Largest Underserved Market and Biggest Growth Opportunity
Why women's health is a large, neglected market, and how much value is lost when medicine is designed around the wrong default patient.
with Eir Accelerator, European Investment Bank, Women's Health Fund +2 more
Therapeutic InsightsBusiness of Biotech

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at UCB

Tell us what you sell and we’ll find the people at UCB most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction